The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

By sjmartinez • March 25, 2025

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi T, Pillinger MH, Riggs KR, Saag KG, Shekelle PG, Tseng Z, Toprover M, Wei DS, Barry MJ, Choi HK. The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. ACR Open Rheumatol. 2025 Mar;7(3):e70012. doi: 10.1002/acr2.70012. PMID: 40126890.

Tags: General Internal Medicine, Publications, Rheumatology, Veterans Administration

Donna L. Washington, MD, MPH, FACP Appointed Section Chief of General Internal Medicine at the VA Greater Los Angeles Healthcare System

It is with great pleasure that we announce the appointment of Donna L. Washington, MD, MPH, FACP as the incoming section chief of General Internal Medicine at[...]

Effect of Language Interpreter Modalities on Patient Satisfaction and Clinical Workflow: A Pilot Study in a Multidisciplinary Pediatric Craniofacial Clinic

Juang S, Nguyen S, Osman N, Ghodrati K, Reyes C, Maldonado I, Pino J, Duarte M, Halley K, Hendrickson I, Tu M, Peralta JB, Wilhalme[...]

Reframing Opioid Overdose as an Ambulatory Care-Sensitive Condition

Hsu M, Lawrence D, Capone-Newton P, Gelberg L. Reframing Opioid Overdose as an Ambulatory Care-Sensitive Condition. JAMA. 2025 Dec 29. doi: 10.1001/jama.2025.23741. Epub ahead of[...]